Health Canada approves Moderna flu and flu-COVID vaccines for seniors

Health Canada approves Moderna flu and flu-COVID vaccines for seniors

Santé
Connectez-vous pour épingler cet événement

Health Canada approved Moderna's mFLUSIVA influenza vaccine and its mCOFLU combined flu-COVID-19 shot for adults aged 50 and older on 5 November, marking the first time a country has authorized both products. According to CBC, the approval positions Canada as the pioneer in granting regulatory clearance for the two vaccines, and the news was reported on 6 November. The approval follows Moderna's submission of data on the safety and efficacy of the mRNA-based flu vaccine and the flu-COVID combination, which regulators reviewed before granting clearance.

Acteurs

Health Canada Moderna The Canadian Press National Advisory Committee on Immunization Pfizer

Lieux

Canada United States Europe

Vérification des faits

Comment fonctionnent ces métriques
Verdict global: Partiel Confiance: 50% Affirmations: 2
Résumé

There is not enough evidence to confirm that Health Canada authorized Moderna's combined flu-COVID-19 shot for adults aged 50 and older on November 6, 2026. There is also insufficient evidence to verify that Health Canada authorized Moderna's mRNA influenza vaccine for adults aged 50 and older on the same date. It is partially confirmed that Canada is the first country to approve both Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot for adults 50 and older. The claim that Moderna stated their authorized vaccines will not be available in pharmacies before the upcoming respiratory virus season is refuted.

Connectez-vous ou abonnez-vous pour voir l'analyse complète avec les affirmations, les sources et la validation chronologique.

Créer un compte Se connecter

Cette section contient une vérification automatisée des affirmations à partir de sources externes et peut contenir des inexactitudes.

Articles

6 novembre 2026
6 au total
Health Canada approves Moderna’s combined COVID, flu shot for some
Health Canada approves Moderna’s combined COVID, flu shot for some

Global News • 06 nov. 18h55

Health Canada approved Moderna's mFLUSIVA flu vaccine and mCOFLU combined flu-COVID shot for adults aged 50 and older, marking the first country to authorize both products.

Crédibilité 88% Manip. 8% Centre
Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada
Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada

CBC • 06 nov. 16h39

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been authorized for adults 50 and older, making Canada the first country to approve both products.

Crédibilité 92% Manip. 8% Centre
New mRNA vaccines approved by Health Canada
New mRNA vaccines approved by Health Canada

CHCH • 06 nov. 12h42

Health Canada has authorized a combined mRNA COVID-19 and influenza vaccine from Moderna for use in Canada.

Crédibilité 32% Manip. 8% Centre
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines

CityNews Vancouver • 06 nov. 00h36

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have received approval for adults 50 and older, though the company says distribution will miss the upcoming respiratory season.

Crédibilité 88% Manip. 5% Centre
Health Canada approves Moderna’s mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna’s mRNA flu and flu-COVID combo vaccines

CKPG Today • 06 nov. 00h23

Health Canada has approved Moderna's standalone influenza vaccine, mFLUSIVA, and its combined flu-COVID-19 vaccine, mCOFLU, for adults aged 50 and older, making Canada the first country to authorize both products.

Crédibilité 88% Manip. 8% Centre
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines

CityNews Toronto • 06 nov. 00h19

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been approved by Health Canada for adults aged 50 and older, though the company says they will not reach pharmacies before the upcoming respiratory virus season.

Crédibilité 88% Manip. 5% Centre

Événements liés